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Abstract
Intermittent hypoxia causes long-term facilitation (LTF) of respiratory motor nerve activity and
ventilation, which manifests as a persistent increase over the normoxic baseline for an hour or more
after the acute hypoxic ventilatory response. LTF is likely involved in sleep apnea, but its exact role is
uncertain. Previously, LTF was defined as a serotonergic mechanism, but new evidence shows that
multiple signaling pathways can elicit LTF. This raises new questions about the interactions between
signaling pathways in different time domains of the hypoxic ventilatory response, which can no longer
be defined simply in terms of neurochemical mechanisms.
Introduction
During periods of systemic hypoxia (e.g. from lung
disease or high altitude), the body’s first line of defence is
the hypoxic ventilatory response, a reflex increase in
ventilation mediated by arterial chemoreceptors, primar-
ily in the carotid bodies [1]. The hypoxic ventilatory
response is a complex interplay between several distinct
mechanisms whose net effect varies depending on the
pattern and intensity of hypoxic exposure. Depending on
the pattern of hypoxic stimulation, the hypoxic ventila-
tory response may change as a result of short-term effects
that temporarily alter synaptic activity (e.g. increased
neurotransmitter release) or long-term effects that alter
the strength of chemical synapses of ventilatory control
circuits (e.g. receptor modification or new protein
synthesis). These changes result in either facilitation or
depression of ventilation that lasts from seconds to years
[2]. Since such mechanisms alter future ventilatory
responses, they are examples of neuroplasticity in the
ventilatory control system [3]. For example, a train of
brief episodes of intermittent hypoxia results in LTF of
ventilation, which manifests primarily as an increase in
tidal volume that lasts for up to 90 minutes after the final
stimulus [2,4,5]. Alternatively, chronic sustained hypoxia
results in ventilatory acclimatization to hypoxia, which is
an increase in ventilation (mainly breathing frequency)
that lasts for days to weeks following removal of the
hypoxic stimulus [2]. Different time domains of the
hypoxic ventilatory responsemay be involved in different
diseases with hypoxemia, e.g. LTF in sleep apnea with
intermittent hypoxia and ventilatory acclimatization to
hypoxia in chronic obstructive pulmonary disease with
chronic hypoxemia.
In 1998 [2], the different time domains of the hypoxic
ventilatory response were defined and distinguished on
the basis of the following: (1) the pattern and intensity of
hypoxic exposure; (2) the time course of the response
(seconds to years); (3) the effects of this stimuli on the
various physiological components of the hypoxic ventila-
tory response (e.g. breathing frequency and tidal volume);
(4) whether these effects result in an increase or decrease in
ventilation; and (5) the neurochemicals necessary for the
manifestation of these responses [2]. Recently, consider-
able progress has been made in the study of LTF in
particular, and it has become clear that multiple signaling
pathways can cause the same change in ventilation. It
can be expected that specific mechanisms will be activated
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and extinguished at different times depending on species,
experimental preparations and individuals. Thus, defining a
given time domain of a ventilatory response in terms of
a neurochemical or signaling pathway can be ambiguous
when trying to compare resultsbetweendifferent studies. To
resolve thisdilemma,wenowpropose todefine thedifferent
time domains of the hypoxic ventilatory response as
physiological responses to a given hypoxic stimulus, which
may have multiple underlying molecular and cellular
mechanisms. A corollary is that a specific mechanism
shouldnotbeassumedforeachdifferent timedomainof the
hypoxic ventilatory response, and it is critical to specify
a given mechanism if it is important for designing an
experiment or interpreting results about the hypoxic
ventilatory response. Here, we highlight recent work on the
study of LTF to illustrate how multiple signaling pathways
can induce the same physiological hypoxic ventilatory
response.
LTF – historically a serotonin-dependent
pathway
LTF has been observed in a wide variety of animals, both
as increased ventilation (ventilatory LTF) or enhanced
phrenic nerve activity (phrenic LTF) in awake or anes-
thetized animals, respectively [2,6-9]. Ventilatory LTF is
more difficult to study experimentally and appears to
depend on sleep-wakefulness state, species, and the
hypoxic induction protocol; this topic has been expertly
reviewed recently [10,11]. Recent studies show that
ventilatory LTF may be the sum of plasticity in genioglos-
sal, hypoglossal, and intercostal motor responses, in
addition to phrenic responses [2,10,12,13]. Most of the
experimental work defining neurochemicalmechanisms of
LTF has been done in anesthetized animal preparations
and focuses on phrenic LTF. Probably the first description
of LTF in the literature was the report of serotonin-
dependent “afterdischarge” in phrenic activity in anesthe-
tized cats in response to repeated bouts of carotid sinus
nerve stimulation [14,15]. The hypoxic stimulus for LTF
must be intermittent as it is not induced by continuous
hypoxia of the sameduration as the sumof the intermittent
episodes [16].
Until recently, serotonin type 2 receptor (5-HT2R) activa-
tion during, but not after, intermittent hypoxiawas thought
to be the primary signaling mechanism for ventilatory
LTF and phrenic LTF [17-19]. Experimental evidence for
this includes the observations that phrenic LTF induced by
intermittent hypoxia or carotid sinus nerve stimulation
is prevented by 5-HT2R blockade with the general 5-HTR
antagonist methysergide [20], or ketanserin, a specific
5-HT2R antagonist [21-23]. The working model for the
5-HT2mechanism of LTF has been as follows (Fig. 1). First,
episodic hypoxia activates serotonergic Raphe neurons in
the medulla, which results in the release of the neuro-
modulator 5-HT near phrenic motor neurons; such 5-HT
release has been measured when the carotid sinus nerve
is electrically stimulated [24], and there is strong evidence
for it occurring with hypoxia as well [25-29]. 5-HT then
activates a variety of downstream signals that activate
protein kinases to initiate new protein synthesis and
enhance glutamatergic neurotransmission [22,30,31].
Presumably, this involves inserting glutamate receptors
into the post-synaptic membrane and/or phosphorylating
them to enhance sensitivity to pre-synaptic inputs, as
described for other glutamatergic systems [32-34]. How-
ever, it has not been conclusively demonstrated that the
mechanisms of LTF are explicit to synapses on respiratory
motor neurons, and potential roles for changes in cellular
excitability, interneurons, or glia have not been ruled out.
Episodic activation of 5-HT2Rs leads to synthesis of brain-
derived neurotrophic factor (BDNF) in the spinal cord near
the phrenic motorneurons. Evidence supporting this
includes observations that a single intrathecal BDNF
administration induces LTF without a hypoxic stimulus,
and that blocking BDNF translation and protein synthesis
with RNAi approaches abolishes hypoxia-induced LTF [30].
BDNF subsequently activates high-affinity receptor tyrosine
kinases (TrkB), which in turn activate extracellular signal-
regulated kinases 1 and 2 (ERK1/2) [30,35,36]. ERK1/2
regulate glutamatergic receptor phosphorylation and/or
density at the postsynapticmembrane in other systems [37]
and presumably this results in phrenic LTF [22,23].
It is interesting to note that although intermittent, but
not chronic, hypoxic exposures are required to induce
LTF, a single bolus injection of BDNF is sufficient to
activate LTF. This raises interesting questions about the
activation of LTF and how the ventilatory control system
differentiates between patterns of hypoxic exposure.
Presumably, the increase in BDNF with the first bout of
intermittent hypoxia or the start of sustained hypoxia is
not sufficient to induce LTF. However, it is not known
how multiple short bouts of hypoxia increase BDNF
differently to cause LTF.
Chronic intermittent hypoxia, studied by exposing animals
to several hours of intermittent hypoxia per day for
between 4 days to 5 weeks, increases phrenic LTF [23,38].
Increased phrenic LTF with chronic intermittent hypoxia
involves both elevated carotid body chemoreceptor
responses to a given hypoxic stimulus (sensory LTF [39])
and increased central nervous system (CNS) gain of the
hypoxic ventilatory response, which is demonstrated by a
potentiated phrenic nerve response to electrical stimulation
of the carotid sinus nerve [23]. This effect has been reported
in animals treated with intermittent hypoxia using hypoxic
bouts between 15 seconds (plus 68-85 seconds of graded
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hypoxia during the change from normoxia to the target
level of hypoxia) and 5minutes long for several days, but it
does not occur in response to chronic sustained hypoxia
[10,39]. Chronic intermittent hypoxia induces new synth-
esis of the proteins that mediate the LTF pathway [40] and
increases phrenic LTF [23,39]. Interestingly, phrenic LTF
after chronic intermittent hypoxia still depends on 5-HT2Rs,
but the increment in phrenic LTF with chronic versus acute
intermittent hypoxia involves central (versus carotid body)
effects of a different subtype of 5-HTR, which is sensitive to
methysergide [23]. This finding provided early evidence
that LTF could be regulated by multiple mechanisms (see
below).
LTF without serotonin
More recent studies challenged the idea that serotonergic
inputs are necessary to induce LTF. For example, activation
of a1-adrenergic receptors can induce phrenic LTF inde-
pendently of 5-HT receptors via a pathway that is media-
ted by protein kinase B (Akt) instead of ERKs [41,42].
Interestingly, both a1-adrenergic receptors and 5-HT
receptors are coupled to Gq-proteins, a class of g-protein
that is linked to the activity of phospholipase C [43],
suggesting that these two types of receptormay converge on
a common pathway and serve as common activators of
LTF. It has been proposed that these two mechanisms
form a pathway termed the “Q” Pathway (Fig. 2) [44].
Figure 1. Classic model of signaling for phrenic long-term facilitation
A
B
Intermittent hypoxia increases ventilatory drive during acute hypoxia and normoxic (baseline) ventilation remains elevated for over an hour after intermittent
hypoxia. (A)Carotid body stimulation by IH releases serotonin (5-HT) from neuromodulatory Raphe neurons, which binds to 5-HT type 1A and 2A receptors on
phrenic motorneurons. 5-HT activates Gq protein signaling cascades to activate protein kinase C (PKC) and induce the synthesis of brain-derived neurotrophic
factor (BDNF). BDNF binds to tyrosine kinase receptors (TrkB) that activate phospho-extracellular signal regulated kinase (pERK). In other systems, pERK has been
shown to phosphorylate glutamatergic N-methyl-D-aspartate receptors (NMDARs) in post-synaptic neurons and increase sensitivity to pre-synaptic glutamate
release. (B) Physiologically, this increased sensitivity manifests as enhanced phrenic nerve activity and increased ventilation (primarily increased tidal volume).
Figure 1 is modified from [44,53].
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Recently, another signaling pathway capable of inducing
phrenic LTF has been reported, and it is mediated by
spinal cord adenosine type 2A receptors (A2AR) [45-47]
and 5-HT7Rs [45-48]. A2ARs signal through adenylate
cyclase-coupled Gs proteins, and, accordingly, this path-
way has been termed the “S” pathway (Fig. 2) [44].
Support for the idea that Gs signaling has a more general
role in LTF comes from the observation that 5-HT7Rs,
which also utilize Gs, can induce long-lasting phrenic
motor facilitation [48]. It is possible that 5-HT7Rs play
a role in the enhanced phrenic LTF observed with chronic
intermittent hypoxia (see above). Interestingly, the S
Pathway involves activation of immature TrkB indepen-
dently of BDNF synthesis and this pathway proceeds
through the activation of PI3K/Akt, but does not involve
ERKs [45]. The S and Q pathways are simultaneously
initiated by intermittent hypoxia but they tend to limit
each other, since blocking only one pathway increases
phrenic LTF [44,46]. This interaction is typical of Gs
and Gq proteins, which interfere with each other via
a well-described cross-talk mechanism in other systems
[49]. This cross-talk may involve reactive oxygen species
[46], which are involved in phrenic LTF and ventilatory
LTF [50-54] (the effects of reactive oxygen species on
LTF are beyond the scope of this brief review). The
physiological significance of the dual G protein mech-
anisms for the hypoxic ventilatory response may relate
to the recent discovery that different levels of hypoxia
induce different pathways for phrenic LTF, such that
more severe hypoxic episodes (25-30 mmHg PaO2)
preferably induce the S Pathway, whereas during
moderate hypoxia (45-55 mmHg PaO2), the Q pathway
is favoured [47].
In addition to these pathways, signaling mechanisms
mediated by vascular endothelial growth factor [55], and
erythropoietin [56], have also recently been described,
and both pathways interact with ERK and Akt signaling
[44,55-58]. It remains to be seen how these mechanisms
utilize components of the Q and S pathways, or if they
represent entirely new signaling mechanisms that med-
iate phrenic LTF.
Figure 2. New model for phrenic long-term facilitation with multiple signaling pathways
The Gq pathway (blue arrows) proceeds as described in Fig. 1A but can also be activated by a1-adrenergic receptors (a1R) and less severe hypoxia than
the Gs pathway [47]. The Gs pathway (green arrows) can be induced by the activation of adenosine type 2A receptors (A2AR) or serotonin type 7 receptors
(5-HT7R), which are coupled to Gs proteins. Gs signaling activates protein kinase A (PKA), which stimulates immature TrkB to modulate phospho-protein
kinase B (pAkt). In other systems, this phosphorylates glutamatergic N-methyl-D-aspartate receptors (NMDARs) and increases sensitivity to pre-synaptic
glutamate release. Recently, additional pathways (dashed arrows) have been described wherein vascular endothelial growth factor receptor-2 (VEGFR-2) or
erythropoietin receptor (EPOR) induce LTF via phosphoinositide 3-kinase (PI3K) and pAkt, and perhaps pERK. Potential effects of reactive oxygen species on Gs
and Gq pathway interactions are not shown. Figure 2 is modified from [44].
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Beyond LTF, the Q and S pathways are important
modulators of a variety of respiratory and non-respiratory
circuits that mediate both sensory and motor systems. For
example, the Gs pathway has been implicated in several
related processes: the regulation of heart rate by sympa-
thetic and vagal nerve b–adrenergic inputs to cardiac
pacemaker cells [59]; the control of respiratory depression
during rapid eye movement (REM) sleep via a mechanism
involving adenylyl cyclase [60]; and the sensitivity of
inhibitory glycine receptors, which play important roles in
motor control, pain, and ventilation [61,62]. Similarly, the
Q pathway has been implicated in central pattern gener-
ation of respiratory control in the brainstem of juvenile rats
[63], while interactions between the Q pathway and other
G protein receptors mediate Purkinje cell signaling in the
coordination of motor control [64]. In general, the activity
of the various G proteins and their interactions occur via
highly conserved signaling pathways, so research in other
areas will likely prove valuable for understanding of the
roles of these pathways in LTF, and vice versa.
Age, gender, and strain in the manifestation
of LTF
An important caveat to this research is that the majority of
studies have been undertaken in young male Sprague-
Dawley rats. Sex hormones regulate plasticity in the CNS,
including those for ventilatory responses to intermittent
hypoxia [65,66]. Research has demonstrated that the
magnitude of phrenic LTF ismarkedly reduced in old versus
young male Sprague-Dawley rats (13 vs. 3-4 months), and
LTF of the hypoglossal nerve is abolished in the older
population [67]. This effect has been linked to the
expression of sex hormones and LTF of the phrenic and
hypoglossal nerves is similarly abrogated in gonadecto-
mised or agedmale Fischer 344 rats relative to young intact
animals; the decrease in hypoglossal LTF correlates with
decreased expression of the sex hormones testosterone,
progesterone, and oestradiol [68], and testosterone supple-
mentation reverses the effects of gonadectomy [69], or aging
[70]. Furthermore, the expression of LTF has also been
shown to vary between different strains of rats, such that
acute intermittent hypoxia-induced changes in 5-HT
signaling, phrenic LTF, and LTF of the hypoglossal nerve
are not observed in Brown Norway rats, and are more
pronounced in Lewis rats than in Fischer 344 rats [71,72].
This indicates that genetic and epigenetic differences may
also contribute to the extent to which LTF is induced
by intermittent hypoxia.
Conclusions
New experiments demonstrate multiple pathways for the
physiological expression of LTF of respiratory motor
activity following intermittent hypoxia. Hence, a given
neurochemical mechanism cannot be used to define a
given time domain of the hypoxic ventilatory response.
Thephysiological significance for differentmechanisms for
LTF remains to be determined and, in particular, differ-
ences in sensitivity of the Q versus S pathways to various
patterns of intermittent hypoxia remain to be tested. Also,
the idea that LTF and ventilatory acclimatization to chronic
sustained hypoxia use different signaling mechanisms can
be questioned; a critical argument supporting different
mechanisms for these two forms of plasticity has been that
themechanismof LTF requires serotonin,while ventilatory
acclimatization to hypoxia does not [2]; however, the
recent discovery of serotonin-independent LTF nullifies
this distinction. Finally, the clinical significance of LTF
and its role in sleep-disordered breathing remains to
be determined. Depending on how LTF affects indivi-
dual ventilatory and upper airway muscles, loop gain,
and ventilatory thresholds, LTF might stabilize or destabi-
lize breathing with intermittent hypoxia during sleep-
disordered breathing [73-75].
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